Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor

被引:373
作者
Schindler, T
Sicheri, F
Pico, A
Gazit, A
Levitzki, A
Kuriyan, J
机构
[1] Rockefeller Univ, Lab Mol Biophys, New York, NY 10021 USA
[2] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA
[3] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel
关键词
D O I
10.1016/S1097-2765(00)80357-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The crystal structure of the autoinhibited form of Hck has been determined at 2.0 Angstrom resolution, in complex with a specific pyrazolo pyrimidine-type inhibitor, PP1. The activation segment, a key regulatory component of the catalytic domain, is unphosphorylated and is visualized in its entirety. Tyr-416, the site of activating autophosphorylation in the Src family kinases, is positioned such that access to the catalytic machinery is blocked. PP1 is bound at the ATP-binding site of the kinase, and a methylphenyl group on PP1 is inserted into an adjacent hydrophobic pocket. The enlargement of this pocket in autoinhibited Src kinases suggests a route toward the development of inhibitors that are specific for the inactive forms of these proteins.
引用
收藏
页码:639 / 648
页数:10
相关论文
共 46 条
[1]   CHARACTERIZATION OF PP60(C-SRC) TYROSINE KINASE-ACTIVITIES USING A CONTINUOUS ASSAY - AUTOACTIVATION OF THE ENZYME IS AN INTERMOLECULAR AUTOPHOSPHORYLATION PROCESS [J].
BARKER, SC ;
KASSEL, DB ;
WEIGL, D ;
HUANG, XY ;
LUTHER, MA ;
KNIGHT, WB .
BIOCHEMISTRY, 1995, 34 (45) :14843-14851
[2]   Leukocyte protein tyrosine kinases: Potential targets for drug discovery [J].
Bolen, JB ;
Brugge, JS .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :371-404
[3]   Regulation, substrates and functions of src [J].
Brown, MT ;
Cooper, JA .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1996, 1287 (2-3) :121-149
[4]   Crystallography & NMR system:: A new software suite for macromolecular structure determination [J].
Brunger, AT ;
Adams, PD ;
Clore, GM ;
DeLano, WL ;
Gros, P ;
Grosse-Kunstleve, RW ;
Jiang, JS ;
Kuszewski, J ;
Nilges, M ;
Pannu, NS ;
Read, RJ ;
Rice, LM ;
Simonson, T ;
Warren, GL .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 :905-921
[5]   RIBBONS 2 0 [J].
CARSON, M .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1991, 24 :958-&
[6]   CRYSTAL-STRUCTURE OF CYCLIN-DEPENDENT KINASE-2 [J].
DEBONDT, HL ;
ROSENBLATT, J ;
JANCARIK, J ;
JONES, HD ;
MORGAN, DO ;
KIM, SH .
NATURE, 1993, 363 (6430) :595-602
[7]   An extensively modified version of MolScript that includes greatly enhanced coloring capabilities [J].
Esnouf, RM .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 1997, 15 (02) :132-+
[8]  
FERRACINI R, 1990, ONCOGENE RES, V5, P205
[9]   A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase [J].
Fox, T ;
Coll, JT ;
Xie, XL ;
Ford, PJ ;
Germann, UA ;
Porter, MD ;
Pazhanisamy, S ;
Fleming, MA ;
Galullo, V ;
Su, MSS ;
Wilson, KP .
PROTEIN SCIENCE, 1998, 7 (11) :2249-2255
[10]   The role of the linker between the SH2 domain and catalytic domain in the regulation and function of Src [J].
Gonfloni, S ;
Williams, JC ;
Hattula, K ;
Weijland, A ;
Wierenga, RK ;
Superti-Furga, G .
EMBO JOURNAL, 1997, 16 (24) :7261-7271